Author Correction: Genomics of disease risk in globally diverse populations (Nature Reviews Genetics, (2019), 20, 9, (520-535), 10.1038/s41576-019-0144-0);Genomics of disease risk in globally diverse populations

Nature Reviews Genetics

Volumn 20, Issue 9, 2019, Pages 520-535

  Gurdasani, Deepti ^a,b   Barroso, Inês ^a,b   Zeggini, Eleftheria ^c   Sandhu, Manjinder S ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85068044444     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/s41576-019-0153-z     Document Type: Erratum

References (133)

1. Hindorff, L. A. et al. Prioritizing diversity in human genomics research. Nat. Rev. Genet. 19, 175–185 (2018). This article presents an insightful review focusing on the need for increased diversity in human genetics research, and efforts by the NHGRI to increase diversity in participants as well as researchers.
2. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015). A landmark study from the 1000 Genomes Project Consortium outlining the first whole-genome sequencing study of multiple diverse ethnic groups providing novel insights into differences in genomic variation across different populations.
3. Gurdasani, D. et al. The African Genome Variation Project shapes medical genetics in Africa. Nature 517, 327–332 (2014). This study is one of the first comprehensive evaluations of genetic diversity among different ethno-linguistic groups within Africa based on genotyping data.
4. Mallick, S. et al. The Simons Genome Diversity Project: 300 genomes from 142 diverse populations. Nature 538, 201–206 (2016). A study of highly genetically diverse populations across the globe using deep whole-genome sequencing approaches.
5. MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45, D896–D901 (2017).
6. Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019). This article provides a summary of data within the GWAS catalogue (a collection of all GWAS study data deposited to date), including the ethnic distribution of existing studies.
7. Morales, J. et al. A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog. Genome Biol. 19, 21 (2018).
8. McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
9. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
10. Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017). This article presents an excellent overview of the history of GWAS and their role in discovery of genetic determinants of disease.
11. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014).
12. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010).
13. Dries, D. L. Genetic ancestry, population admixture, and the genetic epidemiology of complex disease. Circ. Cardiovasc. Genet. 2, 540–543 (2009).
14. Yang, J. et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat. Genet. 47, 1114–1120 (2015).
15. Ruhle, F. et al. Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism. Blood 129, 783–790 (2017).
16. Ng, S. B. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42, 790–793 (2010).
17. Auer, P. L. & Lettre, G. Rare variant association studies: considerations, challenges and opportunities. Genome Med. 7, 16 (2015).
18. Marigorta, U. M. & Navarro, A. High trans-ethnic replicability of GWAS results implies common causal variants. PLOS Genet. 9, e1003566 (2013).
19. Waters, K. M. et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLOS Genet. 6, e1001078 (2010).
20. Haiman, C. A. et al. Consistent directions of effect for established type 2 diabetes risk variants across populations: the Population Architecture using Genomics and Epidemiology (PAGE) Consortium. Diabetes 61, 1642–1647 (2012).
21. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234–244 (2014).
22. Gravel, S. et al. Demographic history and rare allele sharing among human populations. Proc. Natl Acad. Sci. USA 108, 11983–11988 (2011).
23. Kim, M. S., Patel, K. P., Teng, A. K., Berens, A. J. & Lachance, J. Genetic disease risks can be misestimated across global populations. Genome Biol. 19, 179 (2018). This article presents an important study examining the transferability of polygenic risk scores across different ethnic groups.
24. Ioannidis, J. P., Ntzani, E. E. & Trikalinos, T. A. ‘Racial’ differences in genetic effects for complex diseases. Nat. Genet. 36, 1312–1318 (2004).
25. Ntzani, E. E., Liberopoulos, G., Manolio, T. A. & Ioannidis, J. P. Consistency of genome-wide associations across major ancestral groups. Hum. Genet. 131, 1057–1071 (2012).
26. Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171–192 (2005).
27. Lipson, M. et al. Ancient genomes document multiple waves of migration in Southeast Asian prehistory. Science 361, 92–95 (2018).
28. Pickrell, J. K. & Reich, D. Toward a new history and geography of human genes informed by ancient DNA. Trends Genet. 30, 377–389 (2014).
29. Posth, C. et al. Reconstructing the deep population history of Central and South America. Cell 175, 1185–1197 (2018).
30. Skoglund, P. et al. Reconstructing prehistoric African population structure. Cell 171, 59–71 (2017).
31. Prufer, K. et al. The complete genome sequence of a Neanderthal from the Altai Mountains. Nature 505, 43–49 (2014).
32. Meyer, M. et al. A high-coverage genome sequence from an archaic Denisovan individual. Science 338, 222–226 (2012).
33. Hammer, M. F., Woerner, A. E., Mendez, F. L., Watkins, J. C. & Wall, J. D. Genetic evidence for archaic admixture in Africa. Proc. Natl Acad. Sci. USA 108, 15123–15128 (2011).
34. Lachance, J. et al. Evolutionary history and adaptation from high-coverage whole-genome sequences of diverse African hunter-gatherers. Cell 150, 457–469 (2012).
35. Sankararaman, S., Mallick, S., Patterson, N. & Reich, D. The combined landscape of Denisovan and Neanderthal ancestry in present-day humans. Curr. Biol. 26, 1241–1247 (2016).
36. Xu, D. et al. Archaic hominin introgression in Africa contributes to functional salivary MUC7 genetic variation. Mol. Biol. Evol. 34, 2704–2715 (2017).
37. Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017). This article presents an important study examining the transferability of polygenic risk scores across different ethnic groups.
38. Rosenberg, N. A. et al. Genome-wide association studies in diverse populations. Nat. Rev. Genet. 11, 356–366 (2010).
39. Yasuda, K. et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40, 1092–1097 (2008).
40. Unoki, H. et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098–1102 (2008).
41. Pulit, S. L., Voight, B. F. & de Bakker, P. I. Multiethnic genetic association studies improve power for locus discovery. PLOS ONE 5, e12600 (2010). This article presents an important study of how inclusion of multi-ethnic populations influences power for discovery in GWAS, in comparison with inclusion of homogeneous populations.
42. Mathieson, I. & McVean, G. Differential confounding of rare and common variants in spatially structured populations. Nat. Genet. 44, 243–246 (2012).
43. Novembre, J., Galvani, A. P. & Slatkin, M. The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLOS Biol. 3, e339 (2005).
44. Franceschini, N., Reiner, A. P. & Heiss, G. Recent findings in the genetics of blood pressure and hypertension traits. Am. J. Hypertens. 24, 392–400 (2011).
45. Yasukochi, Y. et al. Longitudinal exome-wide association study to identify genetic susceptibility loci for hypertension in a Japanese population. Exp. Mol. Med. 49, e409 (2017).
46. Kent, S. T. et al. PCSK9 loss-of-function variants, low-density lipoprotein cholesterol, and risk of coronary heart disease and stroke: data from 9 studies of blacks and whites. Circ. Cardiovasc. Genet. 10, e001632 (2017).
47. Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264–1272 (2006).
48. Dhandapany, P. S. et al. A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat. Genet. 41, 187–191 (2009).
49. Mefford, H. C. et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann. Neurol. 70, 974–985 (2011).
50. Miller, D. T. et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86, 749–764 (2010).
51. Li, J. et al. Whole genome distribution and ethnic differentiation of copy number variation in Caucasian and Asian populations. PLOS ONE 4, e7958 (2009).
52. Cook, J. P. & Morris, A. P. Multi-ethnic genome-wide association study identifies novel locus for type 2 diabetes susceptibility. Eur. J. Hum. Genet. 24, 1175–1180 (2016).
53. Ioannidis, J. P., Patsopoulos, N. A. & Evangelou, E. Heterogeneity in meta-analyses of genome-wide association investigations. PLOS ONE 2, e841 (2007).
54. Jing, L., Su, L. & Ring, B. Z. Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review. PLOS ONE 9, e97522 (2014).
55. Magi, R. et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum. Mol. Genet. 26, 3639–3650 (2017).
56. Holmes, M. V. et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378, 584–594 (2011).
57. Helgason, A. et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat. Genet. 39, 218–225 (2007).
58. Moonesinghe, R., Khoury, M. J., Liu, T. & Ioannidis, J. P. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc. Natl Acad. Sci. USA 105, 617–622 (2008).
59. Kulminski, A. M. et al. Explicating heterogeneity of complex traits has strong potential for improving GWAS efficiency. Sci. Rep. 6, 35390 (2016).
60. Lee, C. H., Eskin, E. & Han, B. Increasing the power of meta-analysis of genome-wide association studies to detect heterogeneous effects. Bioinformatics 33, i379–i388 (2017). This study outlines an important meta-analytic method to maximize power to detect associations in multi-ethnic GWAS with heterogeneous effects.
61. The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
62. Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
63. GTEx Consortium et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
64. Martin, A. R. et al. Transcriptome sequencing from diverse human populations reveals differentiated regulatory architecture. PLOS Genet. 10, e1004549 (2014).
65. Mele, M. et al. Human genomics. The human transcriptome across tissues and individuals. Science 348, 660–665 (2015).
66. Tian, L. et al. Genome-wide comparison of allele-specific gene expression between African and European populations. Hum. Mol. Genet. 27, 1067–1077 (2018).
67. Kelly, D. E., Hansen, M. E. B. & Tishkoff, S. A. Global variation in gene expression and the value of diverse sampling. Curr. Opin. Syst. Biol. 1, 102–108 (2017).
68. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506–511 (2013). Thie study is one of the first investigations of the transcriptome across diverse populations from the 1000 Genomes Project, examining the key differences in gene expression and transcriptome structure among populations.
69. Mogil, L. S. et al. Genetic architecture of gene expression traits across diverse populations. PLOS Genet. 14, e1007586 (2018).
70. Giuliani, C. et al. Epigenetic variability across human populations: a focus on DNA methylation profiles of the KRTCAP3, MAD1L1 and BRSK2 genes. Genome Biol. Evol. 8, 2760–2773 (2016).
71. Fraser, H. B., Lam, L. L., Neumann, S. M. & Kobor, M. S. Population-specificity of human DNA methylation. Genome Biol. 13, R8 (2012).
72. Moen, E. L. et al. Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits. Genetics 194, 987–996 (2013).
73. Husquin, L. T. et al. Exploring the genetic basis of human population differences in DNA methylation and their causal impact on immune gene regulation. Genome Biol. 19, 222 (2018).
74. Hatzikotoulas, K., Gilly, A. & Zeggini, E. Using population isolates in genetic association studies. Brief Funct. Genomics 13, 371–377 (2014).
75. Kristiansson, K., Naukkarinen, J. & Peltonen, L. Isolated populations and complex disease gene identification. Genome Biol. 9, 109 (2008). This review provides an overview of how studying isolated populations has enhanced discovery through GWAS.
76. Dabelea, D. et al. Increasing prevalence of type II diabetes in American Indian children. Diabetologia 41, 904–910 (1998).
77. Knowler, W. C., Bennett, P. H., Hamman, R. F. & Miller, M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am. J. Epidemiol. 108, 497–505 (1978).
78. Schulz, L. O. et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the US. Diabetes Care 29, 1866–1871 (2006).
79. Pollin, T. I. et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702–1705 (2008).
80. Tachmazidou, I. et al. A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nat. Commun. 4, 2872 (2013).
81. Gilly, A. et al. Very low-depth sequencing in a founder population identifies a cardioprotective APOC3 signal missed by genome-wide imputation. Hum. Mol. Genet. 25, 2360–2365 (2016).
82. Moltke, I. et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512, 190–193 (2014).
83. Laitinen, T. et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304, 300–304 (2004).
84. Mockenhaupt, F. P. et al. Alpha(+)-thalassemia protects African children from severe malaria. Blood 104, 2003–2006 (2004).
85. Elguero, E. et al. Malaria continues to select for sickle cell trait in Central Africa. Proc. Natl Acad. Sci. USA 112, 7051–7054 (2015).
86. Luzzatto, L. G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria. Lancet Haematol. 2, e400–e401 (2015).
87. Chen, Z. et al. Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network. Hum. Mol. Genet. 22, 2529–2538 (2013).
88. Hodonsky, C. J. et al. Genome-wide association study of red blood cell traits in Hispanics/Latinos: the Hispanic Community Health Study/Study of Latinos. PLOS Genet. 13, e1006760 (2017).
89. Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46, 1197–1204 (2014).
90. Soranzo, N. et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182–1190 (2009).
91. Hedrick, P. W. Resistance to malaria in humans: the impact of strong, recent selection. Malar. J. 11, 349 (2012).
92. Ralph, P. & Coop, G. Parallel adaptation: one or many waves of advance of an advantageous allele? Genetics 186, 647–668 (2010).
93. Tennessen, J. A. & Akey, J. M. Parallel adaptive divergence among geographically diverse human populations. PLOS Genet. 7, e1002127 (2011).
94. Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature 442, 39–44 (2006).
95. Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J. A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387–389 (2009).
96. Li, Y. et al. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J. Invest. Dermatol. 130, 2768–2772 (2010).
97. Manolio, T. A. et al. Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 197, 132–138 (2008).
98. Zhu, X. et al. Admixture mapping for hypertension loci with genome-scan markers. Nat. Genet. 37, 177–181 (2005).
99. Zhu, X. & Cooper, R. S. Admixture mapping provides evidence of association of the VNN1 gene with hypertension. PLOS ONE 2, e1244 (2007).
100. Darvasi, A. & Shifman, S. The beauty of admixture. Nat. Genet. 37, 118–119 (2005).
101. Cyr, D. D. et al. Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping. Genes Immun. 18, 95–99 (2017).
102. Freedman, M. L. et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA 103, 14068–14073 (2006).
103. Reich, D. et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat. Genet. 37, 1113–1118 (2005).
104. Scherer, M. L. et al. Admixture mapping of ankle–arm index: identification of a candidate locus associated with peripheral arterial disease. J. Med. Genet. 47, 1–7 (2010).
105. Elbein, S. C., Das, S. K., Hallman, D. M., Hanis, C. L. & Hasstedt, S. J. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort. Diabetes 58, 268–274 (2009).
106. Jeong, C. et al. Admixture facilitates genetic adaptations to high altitude in Tibet. Nat. Commun. 5, 3281 (2014).
107. Bittles, A. H. & Black, M. L. Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases. Proc. Natl Acad. Sci. USA 107 (Suppl. 1), 1779–1786 (2010).
108. Weatherall, D. J. The inherited diseases of hemoglobin are an emerging global health burden. Blood 115, 4331–4336 (2010).
109. Lyons, E. J., Frodsham, A. J., Zhang, L., Hill, A. V. & Amos, W. Consanguinity and susceptibility to infectious diseases in humans. Biol. Lett. 5, 574–576 (2009).
110. Rudan, I. et al. Inbreeding and the genetic complexity of human hypertension. Genetics 163, 1011–1021 (2003).
111. Heckerman, D. et al. Linear mixed model for heritability estimation that explicitly addresses environmental variation. Proc. Natl Acad. Sci. USA 113, 7377–7382 (2016).
112. Saudi Mendeliome Group. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases. Genome Biol. 16, 134 (2015).
113. Asimit, J. L., Hatzikotoulas, K., McCarthy, M., Morris, A. P. & Zeggini, E. Trans-ethnic study design approaches for fine-mapping. Eur. J. Hum. Genet. 24, 1330–1336 (2016). This study assesses the impact of inclusion of populations of different ancestries on resolution of causal loci and shows that fine-mapping is greatly improved by inclusion of individuals of African ancestry.
114. Evangelou, E. & Ioannidis, J. P. Meta-analysis methods for genome-wide association studies and beyond. Nat. Rev. Genet. 14, 379–389 (2013).
115. Hong, J., Lunetta, K. L., Cupples, L. A., Dupuis, J. & Liu, C. T. Evaluation of a two-stage approach in trans- ethnic meta-analysis in genome-wide association studies. Genet. Epidemiol. 40, 284–292 (2016).
116. Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219–1224 (2018).
117. International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011).
118. International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
119. Brown, B. C., Asian Genetic Epidemiology Network Type 2 Diabetes Consortium, Ye, C. J., Price, A. L. & Zaitlen, N. Transethnic genetic-correlation estimates from summary statistics. Am. J. Hum. Genet. 99, 76–88 (2016).
120. Marquez-Luna, C., Loh, P. R., South Asian Type 2 Diabetes Consortium, The SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811–823 (2017).
121. Popejoy, A. B. et al. The clinical imperative for inclusivity: race, ethnicity, and ancestry (REA) in genomics. Hum. Mutat. 39, 1713–1720 (2018).
122. Schrijver, I. et al. The spectrum of CFTR variants in nonwhite cystic fibrosis patients: implications for molecular diagnostic testing. J. Mol. Diagn. 18, 39–50 (2016).
123. Rohlfs, E. M. et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin. Chem. 57, 841–848 (2011).
124. Wheeler, E. et al. Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis. PLOS Med. 14, e1002383 (2017).
125. Johnson, J. A. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 118, 1383–1393 (2008).
126. Caraco, Y., Blotnick, S. & Muszkat, M. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin. Pharmacol. Ther. 83, 460–470 (2008).
127. H3Africa Consortium. Research capacity. Enabling the genomic revolution in Africa. Science 344, 1346–1348 (2014). This work is an important article outlining the H3Africa initiative joint funded through the National Institutes of Health–Wellcome to facilitate genomics research in Africa, with a focus on capacity-building.
128. Petrovski, S. & Goldstein, D. B. Unequal representation of genetic variation across ancestry groups creates healthcare inequality in the application of precision medicine. Genome Biol. 17, 157 (2016).
129. Hormozdiari, F. et al. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits. Nat. Genet. 50, 1041–1047 (2018).
130. Smith, M. W. & O’Brien, S. J. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat. Rev. Genet. 6, 623–632 (2005).
131. Kim, Y. & Nielsen, R. Linkage disequilibrium as a signature of selective sweeps. Genetics 167, 1513–1524 (2004).
132. Voight, B. F., Kudaravalli, S., Wen, X. & Pritchard, J. K. A map of recent positive selection in the human genome. PLOS Biol. 4, e72 (2006).
133. Nagai, A. et al. Overview of the BioBank Japan Project: study design and profile. J. Epidemiol. 27, S2–S8 (2017).